Roger N. Farah - 30 Nov 2024 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Role
Director
Signature
/s/ Roger N. Farah
Issuer symbol
CVS
Transactions as of
30 Nov 2024
Net transactions value
+$2,999,981
Form type
4
Filing time
03 Dec 2024, 17:18:59 UTC
Previous filing
15 Oct 2024
Next filing
21 Jan 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CVS Common Stock (Restricted) Award $2,999,981 +50,125 $59.85 50,125 30 Nov 2024 Direct F1
holding CVS Common Stock 4,124 30 Nov 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CVS Share Credits 36,384 30 Nov 2024 Common Stock 36,384 $0.000000 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in two equal installments, commencing 11/30/2025.
F2 Consists of deferred stock units, each to be converted into one share of common stock and issued pursuant to the Reporting Person's election.